FESCA strategic plan
... “For governments, politicians, doctors, the pharmaceutical industry, and the media, FESCA will be the main focal point for all enquiry. As the EU’s only independent, not-for-profit, focused, umbrella patient organization with deep expertise in Scleroderma, FESCA is in a position to achieve this. Run ...
... “For governments, politicians, doctors, the pharmaceutical industry, and the media, FESCA will be the main focal point for all enquiry. As the EU’s only independent, not-for-profit, focused, umbrella patient organization with deep expertise in Scleroderma, FESCA is in a position to achieve this. Run ...
Trends in Diabetes - 2004
... half of Type II diabetes patients not responding to oral medications will want to use Exenatide to prevent progression of their diabetic condition. Bottom Line: As Diabetes cases continue to rise, these survey results show promise for several new types of therapies and technologies. First, “Increase ...
... half of Type II diabetes patients not responding to oral medications will want to use Exenatide to prevent progression of their diabetic condition. Bottom Line: As Diabetes cases continue to rise, these survey results show promise for several new types of therapies and technologies. First, “Increase ...
Report on the Baseline Survey of Research Activity in
... There is currently no Irish systematic appraisal of research in general. In common with the UK (Rafferty and Traynor, 1997; HEFCE, 2001) very little data exists in Ireland on nursing and midwifery research activity (Condell, 2004). Where information is available there are questions over accuracy, co ...
... There is currently no Irish systematic appraisal of research in general. In common with the UK (Rafferty and Traynor, 1997; HEFCE, 2001) very little data exists in Ireland on nursing and midwifery research activity (Condell, 2004). Where information is available there are questions over accuracy, co ...
Scientific Report 2012-2013 - Institut National Du Cancer
... that INCa has published since 2007. It is an opportunity to thank the Board’s members for advising and guiding the Institute during its structuring process and providing inspiration for its initiatives. As two consecutive plans are drawing to a close and the third national plan is under development, ...
... that INCa has published since 2007. It is an opportunity to thank the Board’s members for advising and guiding the Institute during its structuring process and providing inspiration for its initiatives. As two consecutive plans are drawing to a close and the third national plan is under development, ...
[9] Ifeolu Akinnola, IBP MD/PhD Student
... Early-life iron deficiency (ID) compromises the developing hippocampus, driving adult deficits despite iron repletion. The gene expression changes and regulatory mechanisms that drive these lasting deficits are poorly understood. In previous animal studies of ID, concurrent anemia has been a confoun ...
... Early-life iron deficiency (ID) compromises the developing hippocampus, driving adult deficits despite iron repletion. The gene expression changes and regulatory mechanisms that drive these lasting deficits are poorly understood. In previous animal studies of ID, concurrent anemia has been a confoun ...
South Australian Cancer Research Strategy
... Yet, the challenge of ‘beating cancer’ lies largely ahead of us and much work still needs to be done. For an increasing proportion of the population cancer is a chronic disease, but unfortunately for some in the South Australian community, cancer is still seen as a death sentence and is evidence of ...
... Yet, the challenge of ‘beating cancer’ lies largely ahead of us and much work still needs to be done. For an increasing proportion of the population cancer is a chronic disease, but unfortunately for some in the South Australian community, cancer is still seen as a death sentence and is evidence of ...
UCD Medicine Research - University College Dublin
... This lateral thinking resulted in a fruitful collaboration with NanoTemper Technologies GmbH in Munich to develop a new piece of equipment for molecular analysis. “It will have taken less than one year from initial idea, through to design and soon to reach the market. This could only happen due to t ...
... This lateral thinking resulted in a fruitful collaboration with NanoTemper Technologies GmbH in Munich to develop a new piece of equipment for molecular analysis. “It will have taken less than one year from initial idea, through to design and soon to reach the market. This could only happen due to t ...
Mesothelioma Takes Our Heroes
... Millions more will be spent by lobbyists on all sides of the debate in coming months. The bill’s supporters talk about the need to compensate only the truly sick, such as the mesothelioma patients. They point out that the rash of asbestos-company bankruptcies has hurt shipyard and Navy machinists th ...
... Millions more will be spent by lobbyists on all sides of the debate in coming months. The bill’s supporters talk about the need to compensate only the truly sick, such as the mesothelioma patients. They point out that the rash of asbestos-company bankruptcies has hurt shipyard and Navy machinists th ...
Propelling Innovation in Drug Discovery
... Biomedical innovations—including advances in medicines, medical procedures, and public health—have provided extraordinary benefits to the U.S. public. We live longer and we live healthier than our forebears. Life expectancy at birth has risen from around 47 years at the turn of the 20th century to 7 ...
... Biomedical innovations—including advances in medicines, medical procedures, and public health—have provided extraordinary benefits to the U.S. public. We live longer and we live healthier than our forebears. Life expectancy at birth has risen from around 47 years at the turn of the 20th century to 7 ...
2015 annual report
... celebrate the many successes we have had over the past year, to thank the many people who have given generously of their time, energy and intellect to our organisation and to reflect upon the challenges and opportunities that face us in the future. In relation to successes, we have been able to esta ...
... celebrate the many successes we have had over the past year, to thank the many people who have given generously of their time, energy and intellect to our organisation and to reflect upon the challenges and opportunities that face us in the future. In relation to successes, we have been able to esta ...
Publicly funded Practice-oriented Clinical Trials
... calcium balance in renal failure), André Scheen (analyses results and publications of clinicial studies sponsored by the pharmaceutical industry) Participation in scientific or experimental research as an initiator, principal investigator or researcher: Stéphane Lejeune (EORTC clinical trials in can ...
... calcium balance in renal failure), André Scheen (analyses results and publications of clinicial studies sponsored by the pharmaceutical industry) Participation in scientific or experimental research as an initiator, principal investigator or researcher: Stéphane Lejeune (EORTC clinical trials in can ...
connect20 - Parent Project Muscular Dystrophy
... study site will provide you with the study medication free of charge, should you be placed in an arm involving the use of a study medication. You will not be charged for additional tests and procedures that are performed only because you are participating in this research. Your responsibility to pay ...
... study site will provide you with the study medication free of charge, should you be placed in an arm involving the use of a study medication. You will not be charged for additional tests and procedures that are performed only because you are participating in this research. Your responsibility to pay ...
Chapter 14: Semantic Interpretation for the Biomedical Research Literature
... geographic locations, are stored in a hierarchical knowledge structure, which was specifically constructed for this application. Initial processing concentrates on syntactic patterns to find the entities that can serve as arguments. In addition to noun phrases, verb groups such as were killed are id ...
... geographic locations, are stored in a hierarchical knowledge structure, which was specifically constructed for this application. Initial processing concentrates on syntactic patterns to find the entities that can serve as arguments. In addition to noun phrases, verb groups such as were killed are id ...
Industry-sponsored clinical drug trials in Egypt: Ethical
... Declaration et. al., June 2016. Edited by Berne Declaration, Centre for Research on Multinational Corporations (SOMO), Wemos Foundation, the Egyptian Initiative for Personal Rights and Shamseya for Innovative Community Healthcare Solutions. ...
... Declaration et. al., June 2016. Edited by Berne Declaration, Centre for Research on Multinational Corporations (SOMO), Wemos Foundation, the Egyptian Initiative for Personal Rights and Shamseya for Innovative Community Healthcare Solutions. ...
Canada`s Clinical Trial Infrastructure: A Prescription for Improved
... General of Canada, representatives from the pharmaceutical and clinical trial industries, patient advocacy groups, medical, ethical and legal academics and finally representatives of research ethics boards. ...
... General of Canada, representatives from the pharmaceutical and clinical trial industries, patient advocacy groups, medical, ethical and legal academics and finally representatives of research ethics boards. ...
Collaborative researCh Update 2010/2011
... Horvath has published 24 original research papers published in peer-reviewed journals in the last 10 years. She has presented extensively at national and international meetings both peer-reviewed and invited presentations. Dr Horvath’s research interest is predominantly on tissue biomarkers of progn ...
... Horvath has published 24 original research papers published in peer-reviewed journals in the last 10 years. She has presented extensively at national and international meetings both peer-reviewed and invited presentations. Dr Horvath’s research interest is predominantly on tissue biomarkers of progn ...
• The body needs to make it (you can not absorb it from the diet
... Response to Intravenous NAD BR+ Therapy in Subjects Treated for Opiate Abuse ...
... Response to Intravenous NAD BR+ Therapy in Subjects Treated for Opiate Abuse ...
Arthritis Research Theme 2012 Report
... outstanding and significant research activity. This decision is a constructive and practical development for those people with arthritis as it not only highlights the significant amount of research being done across the university into all forms of arthritis, but also encourages further clinical res ...
... outstanding and significant research activity. This decision is a constructive and practical development for those people with arthritis as it not only highlights the significant amount of research being done across the university into all forms of arthritis, but also encourages further clinical res ...
Human Biological Material: Recommendations for Collection, Use
... The collection of human biological samples and their importance and value to medical research is neither a matter of contention nor debate: for medical research to progress and flourish, medical researchers need to have and to study human biological samples. Much progress in healthcare has been achi ...
... The collection of human biological samples and their importance and value to medical research is neither a matter of contention nor debate: for medical research to progress and flourish, medical researchers need to have and to study human biological samples. Much progress in healthcare has been achi ...
Department of Dermatology, Zurich University Hospital
... and injection treatments for these diseases, and, given its proximity to the clinical trial unit of the dermatology department, also performs up-to-date chemotherapeutic and immunologic anti-tumour treatments which have recently proven to be highly effective against melanoma and other skin cancers s ...
... and injection treatments for these diseases, and, given its proximity to the clinical trial unit of the dermatology department, also performs up-to-date chemotherapeutic and immunologic anti-tumour treatments which have recently proven to be highly effective against melanoma and other skin cancers s ...
Full Text - Clinical Cancer Research
... College Street, Suite 800, Toronto, ON Canada M5G 0A3. Phone: 416673-6532; Fax: 416-977-7446; E-mail: [email protected]. doi: 10.1158/1078-0432.CCR-09-2167 ©2010 American Association for Cancer Research. ...
... College Street, Suite 800, Toronto, ON Canada M5G 0A3. Phone: 416673-6532; Fax: 416-977-7446; E-mail: [email protected]. doi: 10.1158/1078-0432.CCR-09-2167 ©2010 American Association for Cancer Research. ...
Toward Precision Medicine - University of California, San Francisco
... The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare. Upon the authority of the charter granted to ...
... The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare. Upon the authority of the charter granted to ...
Department of Dermatology, Zurich University Hospital
... and injection treatments for these diseases, and, given its proximity to the clinical trial unit of the dermatology department, also performs up-to-date chemotherapeutic and immunologic anti-tumour treatments which have recently proven to be highly effective against melanoma and other skin cancers s ...
... and injection treatments for these diseases, and, given its proximity to the clinical trial unit of the dermatology department, also performs up-to-date chemotherapeutic and immunologic anti-tumour treatments which have recently proven to be highly effective against melanoma and other skin cancers s ...
Adverse Events/Adverse Reactions/Serious Adverse Reactions
... Serious Adverse Drug Reactions (SADR) Suspected Unexpected Serious Adverse Reactions (SUSAR). It sets the principles by which they will be recorded and details the methods by which they are categorised. Moreover in this SOP it will state the Sponsors legal responsibilities in conjunction with th ...
... Serious Adverse Drug Reactions (SADR) Suspected Unexpected Serious Adverse Reactions (SUSAR). It sets the principles by which they will be recorded and details the methods by which they are categorised. Moreover in this SOP it will state the Sponsors legal responsibilities in conjunction with th ...
Medical research
Biomedical research (or experimental medicine) is in general simply known as medical research. It is the basic research, applied research, or translational research conducted to aid and support the development body of knowledge in the field of medicine.An important kind of medical research is clinical research, which is distinguished by the involvement of patients. Other kinds of medical research include pre-clinical research, for example on animals, and basic medical research, for example in genetics.Both clinical and pre-clinical research phases exist in the pharmaceutical industry's drug pipelines, where the clinical phase is denoted by the term clinical trial. However, only part of the whole of clinical or pre-clinical research is oriented towards a specific pharmaceutical purpose. The need for understanding, diagnostics, medical devices and non-pharmaceutical therapies means that medical research is much bigger than just trying to make new drugs.The most basic medical research is a rapidly evolving area that owes much to basic biology and is given names such as Human Biosciences by universities.A new paradigm to biomedical research is being termed translational research, which focuses on iterative feedback loops between the basic and clinical research domains to accelerate knowledge translation from the bedside to the bench, and back again. Medical research may involve doing research into public health, biochemistry, clinical research, microbiology, physiology, oncology, surgery and research into many other non-communicable diseases such as diabetes and cardiovascular diseases.The increased longevity of humans over the past century can be significantly attributed to advances resulting from medical research. Among the major benefits of medical research have been vaccines for measles and polio, insulin treatment for diabetes, classes of antibiotics for treating a host of maladies, medication for high blood pressure, improved treatments for AIDS, statins and other treatments for atherosclerosis, new surgical techniques such as microsurgery, and increasingly successful treatments for cancer. New, beneficial tests and treatments are expected as a result of the Human Genome Project. Many challenges remain, however, including the appearance of antibiotic resistance and the obesity epidemic.Most of the research in the field is pursued by biomedical scientists, however significant contributions are made by other biologists, as well as chemists and physicists. Medical research, done on humans, has to strictly follow the medical ethics as sanctioned in the Declaration of Helsinki and elsewhere. In all cases, the research ethics has to be respected.